Transcatheter Pulmonary Valve Replacement. Current Status and Future Potentials

Interventional Cardiology Clinics

Volumn 2, Issue 1, 2013, Pages 181-193

  Kenny, Damien ^a   Hijazi, Ziyad M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pulmonary; Regurgitation; Stent; Transcatheter; Valve

Indexed keywords

ARTERY COMPRESSION; BACTERIAL ENDOCARDITIS; CARDIOPULMONARY EXERCISE TEST; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEARNING CURVE; LONGEVITY; LUNG HEMORRHAGE; PRIORITY JOURNAL; PROSTHESIS FAILURE; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE REPLACEMENT; REVIEW; SELF EXPANDING STENT; TISSUE ENGINEERING; TRANSCATHETER PULMONARY VALVE REPLACEMENT; TREATMENT OUTCOME; VALVED CONDUIT;

EID: 84870535270     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2012.09.008     Document Type: Review

References (43)

1. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000, 356:1403-1405.
2. Momenah T.S., El Oakley R., Al Najashi K., et al. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009, 53:1859-1863.
3. Boudjemline Y., Legendre A., Ladouceur M., et al. Branch pulmonary artery jailing with a bare metal stent to anchor a transcatheter pulmonary valve in patients with patched large right ventricular outflow tract. Circ Cardiovasc Interv 2012, 5:e22-e25.
4. Guccione P., Milanesi O., Hijazi Z.M., et al. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN™ transcatheter heart valve. Eur J Cardiothorac Surg 2012, 41:1192-1194.
5. Schievano S., Taylor A.M., Capelli C., et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention 2010, 5:745-750.
6. Khambadkone S., Coats L., Taylor A., et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005, 112:1189-1197.
7. Lurz P., Puranik R., Nordmeyer J., et al. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J 2009, 30:2266-2274.
8. Batra A.S., McElhinney D.B., Wang W., et al. Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial. Am Heart J 2012, 163:280-287.
9. Plymen C.M., Bolger A.P., Lurz P., et al. Electrical remodeling following percutaneous pulmonary valve implantation. Am J Cardiol 2011, 107:309-314.
10. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 2000, 102:813-816.
11. Bonhoeffer P., Boudjemline Y., Qureshi S.A., et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002, 39:1664-1669.
12. Lurz P., Coats L., Khambadkone S., et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008, 117:1964-1972.
13. McElhinney D.B., Hellenbrand W.E., Zahn E.M., et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010, 122:507-516.
14. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 113:842-850.
15. Boone R.H., Webb J.G., Horlick E., et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010, 75:286-294.
16. Kenny D., Hijazi Z.M., Kar S., et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 2011, 58:594-598.
17. Oosterhof T., van Straten A., Vliegen H.W., et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007, 116:545-551.
18. Frigiola A., Tsang V., Bull C., et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?. Circulation 2008, 118(Suppl):S182-S190.
19. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008, 118:714-833.
20. Feltes T.F., Bacha E., Beekman R.H., on behalf of the American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 2011, 123:2607-2652.
21. Eicken A., Ewert P., Hager A., et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011, 32:1260-1265.
22. Vezmar M., Chaturvedi R., Lee K.J., et al. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC Cardiovasc Interv 2010, 3:439-448.
23. Lurz P., Giardini A., Taylor A.M., et al. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am J Cardiol 2010, 105:721-726.
24. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
25. Oosterhof T., Vliegen H.W., Meijboom F.J., et al. Long-term effect of pulmonary valve replacement on QRS duration in patients with corrected tetralogy of Fallot. Heart 2007, 93:506-509.
26. Khairy P., Harris L., Landzberg M.J., et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008, 117:363-370.
27. Broberg C.S., Aboulhosn J., Mongeon F.P., Alliance for Adult Research in Congenital Cardiology (AARCC), et al. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of Fallot. Am J Cardiol 2011, 107:1215-1220.
28. Tobler D., Crean A.M., Redington A.N., et al. The left heart after pulmonary valve replacement in adults late after tetralogy of Fallot repair. Int J Cardiol 2012, 160(3):165-170.
29. Coats L., Khambadkone S., Derrick G., et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 2006, 113:2037-2044.
30. Giardini A., Specchia S., Tacy T.A., et al. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am J Cardiol 2007, 99:1462-1467.
31. Brown D.W., McElhinney D.B., Araoz P.A., et al. Reliability and accuracy of echocardiographic right heart evaluation in the U.S. Melody valve investigational trial. J Am Soc Echocardiogr 2012, 25:383-392.
32. McElhinney D.B., Cheatham J.P., Jones T.K., et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011, 4:602-614.
33. Sosnowski C, Kenny D, Hijazi ZM. Bailout use of the Gore Excluder following pulmonary conduit rupture during transcatheter valve replacement. Catheter Cardiovasc Interv, in print.
34. Lurz P., Nordmeyer J., Coats L., et al. Immediate clinical and haemodynamic benefits of restoration of pulmonary valvar competence in patients with pulmonary hypertension. Heart 2009, 95:646-650.
35. Mollet A., Basquin A., Stos B., et al. Off-pump replacement of the pulmonary valve in large right ventricular outflow tracts: a transcatheter approach using an intravascular infundibulum reducer. Pediatr Res 2007, 62:428-433.
36. Lurz P., Nordmeyer J., Giardini A., et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect?. J Am Coll Cardiol 2011, 57:724-731.
37. Batlivala S.P., Emani S., Mayer J.E., et al. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg 2012, 93:2007-2016.
38. Law K.B., Phillips K.R., Butany J. Pulmonary valve-in-valve implants: how long do they prolong reintervention and what causes them to fail?. Cardiovasc Pathol 2012, [Epub ahead of print].
39. Nordmeyer J., Coats L., Lurz P., et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J 2008, 29:810-815.
40. Raikou M., McGuire A., Lurz P., et al. An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J Med Econ 2011, 14:47-52.
41. Gatlin S.W., Kim D.W., Mahle W.T. Cost analysis of percutaneous pulmonary valve replacement. Am J Cardiol 2011, 108:572-574.
42. Nordmeyer J., Tsang V., Gaudin R., et al. Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: impact of in situ homograft geometry on valve competence. Eur Heart J 2009, 30:2147-2154.
43. Butera G., Milanesi O., Spadoni I., et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology (SICP). Catheter Cardiovasc Interv 2012, [Epub ahead of print].